Ultragenyx Pharmaceutical Inc. current report, 08 December 2015

Business Context and Reporting Period

Company: Ultragenyx Pharmaceutical Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: December 8, 2015
Event: Entry into a Material Definitive Agreement (Lease) and creation of a direct financial obligation.

Key Financial Metrics and Obligations

This filing details a specific lease agreement rather than general financial performance metrics. Key financial terms include:

  • Lease Term: 122 months, commencing May 1, 2016, with options to renew for two additional five-year periods.
  • Property Size: Approximately 63,048 square feet at 5000 Marina Boulevard, Brisbane, California.
  • Base Rent: Approximately $170,230 per month ($2.70 per square foot) for the first 12 months, subject to periodic increases.
  • Rent Abatement: Monthly base rent is abated for months 2 through 11 of the lease term, contingent on certain conditions.
  • Default Clause: Unamortized abated rent becomes immediately due and payable in the event of a default.
  • Improvements: Landlord (Marina Boulevard Property, LLC) will fund up to approximately $3.5 million in improvements.
  • Security: Ultragenyx provided a letter of credit of approximately $1.4 million as security.

Note: The filing text does not provide values for revenue, profit, cash flow, margins, total debt, or liquidity.

Material Changes

The filing reports the execution of a new long-term lease agreement. This represents a new contractual obligation and a commitment to future cash outflows for rent and potential improvements, distinct from prior periods.

Outlook, Risks, and Contingencies

  • Contingency: The lease commencement date is subject to the occurrence of certain events described in the agreement.
  • Risk: If the Company defaults, the unamortized amount of abated rent becomes immediately due, creating a potential lump-sum liability.
  • Management Commentary: The filing contains no specific management commentary or forward-looking guidance beyond the terms of the lease.

Investor Verification Checklist

  • Verify the exact commencement date of the lease (May 1, 2016, or earlier).
  • Confirm the specific conditions required for the rent abatement in months 2 through 11.
  • Review the full Lease Agreement (to be filed as an exhibit to the 2015 Form 10-K) for details on periodic rent increases and default triggers.
  • Assess the impact of the $1.4 million letter of credit on the Company's available liquidity.